Log In
Friday 22nd June 2018

New treatment for osteoporosis

22nd June 2010

The National Institute for Health and Clinical Excellence has released draft guidance which states that women with osteoporosis should be offered a new treatment called denosumab.

NICE said that post-menopausal women who did not respond to other treatments could be offered the drug. Dr Carole Longson, director of NICE's Health Technology Evaluation Centre, said: "Our independent appraisal committee felt that there was good-quality evidence to show that denosumab is a useful addition to the treatment options available to prevent a first fracture in women at increased risk and also at preventing further fractures in women who have already experienced one."


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2018